Company Filing History:
Years Active: 2009-2015
Title: Göran Wadell: Innovator in Antiviral Compounds
Introduction
Göran Wadell is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of antiviral research, holding 2 patents that focus on innovative methods for treating viral infections. His work is particularly relevant in the context of adenovirus and herpes virus infections.
Latest Patents
Wadell's latest patents include groundbreaking inventions such as antiviral compounds. These compounds and their pharmacological compositions are designed for the prophylaxis, prevention, and treatment of viral infections, specifically targeting adenovirus and herpes virus infections. Another significant patent is a method and composition for the treatment of adenoviral ocular infections. This invention addresses adenoviral infections, particularly ocular adenoviral infections like keratoconjunctivitis, by administering a substance that interferes with the interaction between the virus and the sialic acid receptor in a therapeutically effective amount.
Career Highlights
Throughout his career, Göran Wadell has worked with various companies, including Eirium AB and Adenovir Pharma AB. His expertise in antiviral research has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Wadell has collaborated with notable colleagues such as Karin Edlund and Marten Strand, contributing to the advancement of antiviral research and the development of innovative treatments.
Conclusion
Göran Wadell's contributions to antiviral research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for new treatments for viral infections.